Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhejiang Taimei Medical Technology Co PS Ratio?
Zhejiang Taimei Medical Technology CoFRA:A2V +1.69%11 PS Ratio is 5.45 as of Aug. 05, 2026, which is 27% above its 10-year median of 4.29. GuruFocus rates FRA:A2V with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Zhejiang Taimei Medical Technology Co ranks worse than 83.11% on this metric.
Zhejiang Taimei Medical Technology Co (FRA:A2V) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Zhejiang Taimei Medical Technology Co PS Ratio Related Terms
Zhejiang Taimei Medical Technology Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Taimei Medical Technology Co PS Ratio Chart
Zhejiang Taimei Medical Technology Co Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
PS Ratio
0.00
0.00
0.00
3.96
3.94
Zhejiang Taimei Medical Technology Co Semi-Annual Data
For the Health Information Services subindustry, Zhejiang Taimei Medical Technology Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Taimei Medical Technology Co PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Zhejiang Taimei Medical Technology Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Zhejiang Taimei Medical Technology Co's PS Ratio falls into.
Zhejiang Taimei Medical Technology Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Zhejiang Taimei Medical Technology Co's Share Price of today is €0.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Zhejiang Taimei Medical Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Zhejiang Taimei Medical Technology Co (FRA:A2V) has a PS Ratio of 5.45 as of Aug. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Zhejiang Taimei Medical Technology Co and its competitors. This is 27% above median its historical median of 4.29. Over the past decade, Zhejiang Taimei Medical Technology Co's PS Ratio has ranged from 2.91 to 7.42. According to the industry distribution chart, Zhejiang Taimei Medical Technology Co ranks #546 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 83.1%.
Is Zhejiang Taimei Medical Technology Co's PS Ratio too high?
Zhejiang Taimei Medical Technology Co's current PS Ratio of 5.45 is 27% above median its 10-year median of 4.29. Over the past 10 years, this metric has ranged from a low of 2.91 to a high of 7.42. The Healthcare Providers & Services industry median PS Ratio is 1.51. Zhejiang Taimei Medical Technology Co's value of 5.45 is 260.9% above this industry median. Based on the distribution chart, Zhejiang Taimei Medical Technology Co ranks #546 out of 657 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Zhejiang Taimei Medical Technology Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Taimei Medical Technology Co's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Zhejiang Taimei Medical Technology Co ranks #546 out of 657 companies for PS Ratio. This places Zhejiang Taimei Medical Technology Co in the lower half of its industry. The industry median PS Ratio is 1.51. Zhejiang Taimei Medical Technology Co's value of 5.45 is 260.9% above this benchmark. Historically, Zhejiang Taimei Medical Technology Co's own PS Ratio has ranged from 2.91 to 7.42 over the past decade. While the company's 10-year median is 4.29 vs. the industry median of 1.51, Zhejiang Taimei Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Taimei Medical Technology Co's current PS Ratio of 5.45 is 260.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Zhejiang Taimei Medical Technology Co and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Taimei Medical Technology Co's current PS Ratio is 5.45, which is 27% above median its own 10-year median of 4.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Taimei Medical Technology Co stock overvalued right now?
Zhejiang Taimei Medical Technology Co (FRA:A2V) has a current PS Ratio of 5.45. The current PS Ratio is 5.45, which is 27% above median its 10-year median of 4.29 and 260.9% above the Healthcare Providers & Services industry median of 1.51. Zhejiang Taimei Medical Technology Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Zhejiang Taimei Medical Technology Co (FRA:A2V), the current PS Ratio is 5.45 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China. It designs and delivers industry-specific software and digital services that facilitate research and development (R&D) and the commercialization of pharmaceuticals and medical devices. The software it offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. It has a geographical presence in Mainland China, the United States, Singapore, Korea, and Others.
11GF Score
Get the complete analysis for FRA:A2V
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A2V has been successfully added to your 
